Rundu Pharma Receives Chemical Drug Approval for Telmisartan on May 18

GateNews

According to Jin10, Rundu Pharma announced on May 18 that it received an approval notice from China’s National Medical Products Administration for telmisartan as a chemical drug substance. Telmisartan is primarily used to treat primary hypertension.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments